Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Silo Wellness Inc. C.SILO

Alternate Symbol(s):  SILFF

Silo Wellness, Inc. is a Canada-based global psychedelics company. The Company is engaged in psilocybin wellness retreats. The Company operates through the Jamaica retreats segment. The Company offers psychedelic wellness retreats in Jamaica and is focused on doing the same in Oregon, United States. The Company also maintains rights in intellectual property (IP). In addition to its IP portfolio, The Company is focusing on consumer product and wellness retreat brand development for psychedelics. It is focusing on improving health and wellness by developing and introducing psychedelic medicine to reduce trauma and increase performance, by destigmatizing the active compounds in psychedelics and innovating ease of administration and ingestion.


CSE:SILO - Post by User

Post by maysilverstoneon May 25, 2021 4:13pm
79 Views
Post# 33261710

Silo Wellness

Silo Wellness
Recently $SILO announced their partnership with Kaivalya Kollectiv, a L.A-based wellness company, to expand their psychedelic offerings of psilocybin and ketamine products to include 5-MeO-DMT. They will operate two 5-MeO-DMT retreats in Jamaica featuring yoga, meditation, breath work, and spiritual coaching. This will be the first partnership by a publicly traded company to offer 5-MeO-DMT retreats and the first to be held in Jamaica.
 
Psychedelic's are becoming more widely accepted and mainstream for mental illness treatment (anxiety, depression, PTSD)- the psychedelic drug market is expected to reach USD $6.8B by 2027 from USD $2B in 2019. I'm keeping an eye on $SILO, holding steady at $0.17, with a mc of $10.64M.
 

<< Previous
Bullboard Posts
Next >>